Adage Capital Partners Gp, L.L.C. Voyager Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$19.18 - $27.88 $7.19 Million - $10.5 Million	-375,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $1.71 Million - $2.17 Million	-100,000 Reduced 21.05%	375,000 $7.1 Million
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $2.91 Million - $5.64 Million	-180,000 Reduced 27.48%	475,000 $8.93 Million
Q4 2017 Feb 14, 2018	SELL	$12.26 - $25.88 $3.92 Million - $8.28 Million	-320,000 Reduced 32.82%	655,000 $10.9 Million
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $8.16 Million - $20.1 Million	975,000	975,000 $20.1 Million

135

34.4M

60.4K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $167M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.